TTNP
Titan Pharmaceuticals
TTNP
TTNP
Delisted
TTNP was delisted on the 1st of October, 2025.
19 hedge funds and large institutions have $374K invested in Titan Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
70% less capital invested
Capital invested by funds: $1.24M → $374K (-$869K)
Holders
19
Holding in Top 10
–
Calls
$6K
Puts
–
Top Buyers
| 1 | +$115K | |
| 2 | +$35K | |
| 3 | +$29.3K | |
| 4 |
HF
HRT Financial
New York
|
+$29K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$11K |
Top Sellers
| 1 | -$826K | |
| 2 | -$73.8K | |
| 3 | -$48K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$10K |